Inhibition of HCV 3a core gene through Silymarin and its fractions. - Wikidata - awgldk - TriplyDB

Inhibition of HCV 3a core gene through Silymarin and its fractions.

Inhibition of HCV 3a core gene through Silymarin and its fractions.

http://www.wikidata.org/entity/Q34809056

about

Herbal products: benefits, limits, and applications in chronic liver disease The hepatitis C virus glycan shield and evasion of the humoral immune response Hepatitis C virus: Promising discoveries and new treatments Antiviral activity of Acacia nilotica against Hepatitis C Virus in liver infected cells Hepatitis C virus and natural compounds: a new antiviral approach?Review article: management of chronic hepatitis C in patients with contraindications to anti-viral therapy.A live gI/gE-deleted pseudorabies virus (PRV) protects weaned piglets against lethal variant PRV challenge.Effects of Silymarin, Glycyrrhizin, and Oxymatrine on the Pharmacokinetics of Ribavirin and Its Major Metabolite in Rats.

P2860

Q21284956-5BCEC73F-DD5E-4910-A282-4EE8297101F0 Q27023390-C921DB91-6E1F-4656-88DD-53953D777880 Q27468916-6E1C0CF8-E5FA-4859-A8D0-68ABD547B3BC Q35047714-BB1586DA-0319-4457-B724-797EA1943D94 Q38064280-E404704D-6F5A-48B0-8FA6-CE146CEF8B2C Q38166445-77341403-9EDD-4057-B88E-F386F4B8D1FF Q40060746-E82D5995-82E1-4C8A-852D-3ED3A3190638 Q40821539-B4174649-8CD7-4FB9-A7EB-359B93745010

P2860

Inhibition of HCV 3a core gene through Silymarin and its fractions.

http://www.wikidata.org/entity/Q34809056

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Inhibition of HCV 3a core gene through Silymarin and its fractions.

@ast

Inhibition of HCV 3a core gene through Silymarin and its fractions.

@en

Inhibition of HCV 3a core gene through Silymarin and its fractions.

@nl

type

label

Inhibition of HCV 3a core gene through Silymarin and its fractions.

@ast

Inhibition of HCV 3a core gene through Silymarin and its fractions.

@en

Inhibition of HCV 3a core gene through Silymarin and its fractions.

@nl

prefLabel

Inhibition of HCV 3a core gene through Silymarin and its fractions.

@ast

Inhibition of HCV 3a core gene through Silymarin and its fractions.

@en

Inhibition of HCV 3a core gene through Silymarin and its fractions.

@nl

P1433

Q34809056-46739BE9-DD21-4B87-A48B-CB156489D35B

P1476

Q34809056-570643D4-17E7-481F-8D82-35329BB5FE5D

P2093

Q34809056-47312F93-3387-4193-A805-6B854ADE8BF9

Q34809056-8B17C2D1-A8B5-44CB-A9BD-CE5D6A3ACA5C

Q34809056-B8074F0C-1F7F-4CDB-8C33-10D5BFD83CBE

Q34809056-FF31A789-32AE-4B84-B8CD-4A2AE20BFF3F

P2860

Q34809056-079991E4-7C0E-4B16-A771-7F0F19FF3AE8

Q34809056-0B07D89F-2C6C-415E-912E-F92BF00C103B

Q34809056-130C333C-4AB5-42F2-87B5-83850D7E7B22

Q34809056-15365157-8B36-4CB8-AF8C-046D7F071CB9

Q34809056-262993FD-DB17-4F81-BF32-347B3BFE29A5

Q34809056-354AD75A-EC06-413F-91C8-753CF08437C4

Q34809056-3D1C99C5-D6A7-405C-BECA-451839AF1181

Q34809056-4B625740-1C13-4B4E-A3A5-98E0AB33B308

Q34809056-59179F0D-3E12-4CA9-8B25-92AA99CA2EFC

Q34809056-6079DB74-210E-4340-B2EE-E90926099541

P304

Q34809056-B5D01637-4825-4373-B4ED-DE6821A7AF53

P31

Q34809056-7418C4F4-09B0-4B34-A267-75881746C99F

P356

Q34809056-C319DD0D-D7B6-40BF-BF92-31369B342116

P478

Q34809056-291E1DC5-7D65-4215-8A1F-3B22BF8E3793

P50

Q34809056-6799B339-2D11-4CAB-982D-874D7AA6259B

P577

Q34809056-A90D8C2D-2741-42D6-9977-CD3BD1F44B02

P698

Q34809056-1BBA2D86-4559-4869-936F-D6E4125F8133

P932

Q34809056-13DDF79B-8F9A-43AC-8B19-B6406AF3C132

P356

1743-422X-8-153

P1433

Virology Journal

P1476

Inhibition of HCV 3a core gene through Silymarin and its fractions

@en

P2093

Sheikh Riazuddin

http://www.w3.org/2001/XMLSchema#string

Sidra Rehman

http://www.w3.org/2001/XMLSchema#string

Tariq Javed

http://www.w3.org/2001/XMLSchema#string

Zafar Nawaz

http://www.w3.org/2001/XMLSchema#string

P2860

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium

The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice

Medicinal herbs for hepatitis C virus infection: a Cochrane hepatobiliary systematic review of randomized trials.

A case-control study of risk factors for hepatitis C infection in patients with unexplained routes of infection.

The use of silymarin in the treatment of liver diseases.

National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002--June 10-12, 2002.

Inhibitors of cytokine signal transduction.

Treatment of chronic hepatitis C with PEGylated interferon and ribavirin.

P304

153

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1743-422X-8-153

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

usman ali Ashfaq

P577

2011-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21453551

http://www.w3.org/2001/XMLSchema#string

P932

3078856

http://www.w3.org/2001/XMLSchema#string